When you include the American Institute for Cancer Research in your estate plans, you make a major difference in the fight against cancer.

Corporate Champions who partner with the American Institute for Cancer Research stand at the forefront of the fight against cancer

40 Years of Progress: Transforming Cancer. Saving Lives.

The AICR Lifestyle & Cancer Symposium addresses the most current and consequential issues regarding diet, obesity, physical activity and cancer.

The Annual AICR Research Conference is the most authoritative source for information on diet, obesity, physical activity and cancer.

Cancer Update Program – unifying research on nutrition, physical activity and cancer.

ResourcesNav New164

Whether you are a healthcare provider, a researcher, or just someone who wants to learn more about cancer prevention, we’re here to help.

Read real-life accounts of how AICR is changing lives through cancer prevention and survivorship.

We bring a detailed policy framework to our advocacy efforts, and provide lawmakers with the scientific evidence they need to achieve our objectives.

AICR champions research that increases understanding of the relationship between nutrition, lifestyle, and cancer.

Are you ready to make a difference? Join our team and help us advance research, improve cancer education and provide lifesaving resources.

AICR’s resources can help you navigate questions about nutrition and lifestyle, and empower you to advocate for your health.

Research Projects > 2019 Grantees

Starving peritoneal metastases to impact ovarian cancer outcomes.

Research Type: Ovarian Cancer

Project Description

Ovarian cancer is the leading cause of death from gynecologic cancers. This project will address how obesity affects response to therapy in models of ovarian cancer that has spread. The researchers hypothesize that changes in the body due to obesity will impact how tumors continue to grow and spread in the body. They will test whether diet-induced obesity affects response to the current standard treatment and whether a new combination therapy aimed at blocking fat synthesis and use by tumor cells improves response.

More News & Updates